NASDAQ$RGNX
REGENXBIO Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
RGNX Q2 2024 — $2.0M revenue
Securities and Exchange Commission (the SEC) for additional discussion of the risks, uncertainties, assumptions and other important factors that could cause our actual results or developments to diffe. REGENXBIO Inc reported Q2 2024 results. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $2.0M.
- Operating income: $56K.
- Filed on Form 10-Q (accession 0000950170-24-089320).
Headline financials
Revenue & EPS history
REGENXBIO · Revenue · Quarterly
$22.3M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2024
+0.8%
Avg return
Earnings day
+2.8%
Avg return
5 days after
+1.7%
Avg return
30 days after
57%
24 / 42 earnings
Positive
+28.0%
Q4 2017
Best reaction
-37.8%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -37.8% | -43.8% | -33.8% | |
| Q4 2025 | -4.7% | +8.3% | -6.7% | |
| Q3 2025 | -3.6% | -0.5% | +13.4% | |
| Q1 2025 | +2.9% | +11.5% | +28.0% | |
| Q4 2024 | +2.6% | +29.8% | -10.1% | |
| Q3 2024 | +25.4% | +29.6% | +7.4% | |
| Q2 2024 | -8.5% | -10.9% | -14.2% | |
| Q1 2024 | -7.5% | -7.2% | -17.0% | |
| Q4 2023 | +8.5% | +15.5% | +14.9% | |
| Q3 2023 | +2.3% | +7.9% | +19.1% | |
| Q2 2023 | -8.7% | -8.4% | -5.3% | |
| Q1 2023 | +2.2% | -5.3% | +1.2% | |
| Q4 2022 | +10.0% | +11.2% | -17.6% | |
| Q3 2022 | -14.5% | -14.2% | +0.1% | |
| Q2 2022 | +9.2% | +9.4% | -6.9% | |
| Q1 2022 | -14.2% | -29.1% | -19.1% | |
| Q4 2021 | +11.1% | +5.3% | +26.6% | |
| Q3 2021 | +4.4% | +8.0% | -12.5% | |
| Q2 2021 | +0.1% | +0.4% | +6.9% | |
| Q1 2021 | +4.8% | +8.8% | +7.4% | |
| Q4 2020 | +1.0% | -2.4% | -16.6% | |
| Q3 2020 | +1.1% | +15.0% | +32.0% | |
| Q2 2020 | -3.4% | -2.5% | -16.9% | |
| Q1 2020 | -5.5% | -2.0% | -9.5% | |
| Q4 2019 | -14.8% | -15.8% | -28.7% | |
| Q3 2019 | -2.6% | +7.5% | +17.3% | |
| Q2 2019 | +0.6% | -8.5% | -22.5% | |
| Q1 2019 | -12.8% | -12.5% | -11.7% | |
| Q4 2018 | -2.2% | +7.0% | +8.3% | |
| Q3 2018 | -1.0% | -10.0% | -24.7% | |
| Q2 2018 | -5.8% | -6.6% | +4.4% | |
| Q1 2018 | +13.2% | +24.0% | +42.8% | |
| Q4 2017 | +28.0% | +22.9% | -3.4% | |
| Q3 2017 | +0.9% | +0.9% | +19.6% | |
| Q2 2017 | +11.8% | +12.4% | +33.3% | |
| Q1 2017 | -4.9% | +0.8% | +9.5% | |
| Q4 2016 | +6.6% | +2.5% | -10.2% | |
| Q3 2016 | +24.6% | +28.5% | +20.7% | |
| Q2 2016 | +0.8% | +21.3% | +41.5% | |
| Q1 2016 | -3.6% | — | — | |
| Q4 2015 | +1.8% | — | — | |
| Q3 2015 | +14.0% | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro